title: Rivaroxaban-induced hair loss.
authors: Department of Pharmacology and Pharmacovigilance, CHU de Caen, Avenue de la Côte de Nacre, CS 30001, CAEN, 14033 Cedex 9, France.
authors: Basile
authors: B
authors: Chrétien
authors: Department of Pharmacology and Pharmacovigilance, CHU de Caen, Avenue de la Côte de Nacre, CS 30001, CAEN, 14033 Cedex 9, France.
authors: Anne
authors: A
authors: Besnard
authors: Department of Pharmacology and Pharmacovigilance, CHU de Caen, Avenue de la Côte de Nacre, CS 30001, CAEN, 14033 Cedex 9, France.
authors: Marion
authors: M
authors: Sassier
authors: Department of Vascular Medicine, CHU de Caen, Caen, 14000, France.
authors: Claire
authors: C
authors: Le Hello
authors: Department of Pharmacology and Pharmacovigilance, CHU de Caen, Avenue de la Côte de Nacre, CS 30001, CAEN, 14033 Cedex 9, France.|Medical School, Université de Caen Normandie, Caen, 14000, France.|Inserm, U1075 COMETE, Medical School, Caen, 14000, France.
authors: Antoine
authors: A
authors: Coquerel
authors: Department of Pharmacology and Pharmacovigilance, CHU de Caen, Avenue de la Côte de Nacre, CS 30001, CAEN, 14033 Cedex 9, France.|Medical School, Université de Caen Normandie, Caen, 14000, France.|EA 4650 Signalisation, électrophysiologie et Imagerie des Lésions d'ischémie-reperfusion Myocardique, Université de Caen Normandie, Caen, 14000, France.|Department of Cardiology, CHU de Caen, Caen, 14000, France.
authors: Joachim
authors: J
authors: Alexandre
authors: Department of Pharmacology and Pharmacovigilance, CHU de Caen, Avenue de la Côte de Nacre, CS 30001, CAEN, 14033 Cedex 9, France. fedrizzi-s@chu-caen.fr.
authors: Sophie
authors: S
authors: Fedrizzi
mesh_terms: D000328:Adult; D000505:Alopecia / Q000139:chemically induced*; D065427:Factor Xa Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000069552:Rivaroxaban / Q000009:adverse effects*
chemical_list: D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban